FDA
-
-
-
-
-
-
-
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
-
-
-
-
-
-
-
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
-
-
-
-
-
-
-
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan
-
-
-
-
-
-
-
Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19)
-
-
-
-
-
-
-
NCCN issues first pediatric acute lymphoblastic leukemia guidelines, including use of Voraxaze®
-
-
-
-
-
-
-
Brexit, trade progress drive European stocks up after tech rout
-
-
-
-
-
-
-
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

